CURRICULUM VITAE STEVEN MICHAEL TEUTSCH, M.D., M.P.H. TRAINING AND EXPERIENCE:

1954 - 1966 Primary and Secondary Education

Salt Lake City, Utah

1966 - 1970 Harvard College Cambridge, Massachusetts B.A., Biochemical Sciences Cum Laude 1970 - 1974 Duke University Medical School Durham, North Carolina M.D. 1972 - 1973 University of North Carolina School of Public Health Chapel Hill, North Carolina M.P.H., Epidemiology 1974 - 1977 Pennsylvania State University Hershey Medical Center Hershey, Pennsylvania Internship and Residency Internal Medicine

1977 - 1979 Epidemic Intelligence Officer Parasitic Diseases Division Bureau of Epidemiology Centers for Disease Control

Atlanta, Georgia 1979 - 1981 Chief, Kidney Disease Activity Center for Prevention Services Centers for Disease Control Atlanta, Georgia 1981 - 1983 Chief, Operational Research

Division of Diabetes Control Center for Prevention Services Centers for Disease Control Atlanta, Georgia

1983 - 1987 Chief, Technical and Operational Research Branch Division of Diabetes Control Center for Prevention Services Centers for Disease Control Atlanta, Georgia

1987 - 1988 Chief, Epidemiologic Studies Branch

Division of Surveillance and Epidemiologic Studies Epidemiology Program Office Centers for Disease Control Atlanta, Georgia

1988 - 1991 Director, Division of Surveillance and Epidemiology

Epidemiology Program Office Centers for Disease Control Atlanta, Georgia

1991 - 1996 Special Assistant to the Director and

Chief, Prevention Effectiveness Activity Epidemiology Program Office Centers for Disease Control and Prevention Atlanta, Georgia

1996 - 1997 Director, Division of Prevention Research and Analytic Methods

Epidemiology Program Office Centers for Disease Control and Prevention Atlanta, Georgia

1997 - 1998 Senior Research Scientist Outcomes Research & Management Merck & Co., Inc. West Point, PA 1998 - 2007 Senior Director (Executive Director, 2001) Outcomes Research & Management Merck & Co., Inc. West Point, PA 2007 – 2008 Executive Director US Outcomes Research Merck & Co., Inc., West Point, PA

2

2009 -- 2014 Chief Science Officer Los Angeles County Department of Public Health

Los Angeles, CA OTHER POSITIONS: 1980-1982 Member, National Center for Health Care Technology Technology Coordinating Committee End Stage Renal Disease Subcommittee

1981-1983 Medical Advisory Board, Centers for Disease Control 1983 U.S. Public Health Service End Stage Renal Disease Coordinating Committee

1983 Surgeon General's Conference on Organ Transplantation 1983 - 1984 Consultant to the Carter Center. Prepared diabetes section for Carter Center

Closing the Gap Project. 1985 - 1986 Consultant to Carter Center Health Risk Appraisal Project 1985 - 1987 Consultant, National Office of Organ Transplantation 1986 - 1987 Surveillance Coordination Group, Chronic Disease Surveillance Subcommittee 1987 - 1989 National Kidney and Urologic Disease Advisory Board 1987 - 1989 National Kidney, Urologic, and Hematologic Diseases Interagency Coordinating

Council 1988 - 1991 Chairman, Centers for Disease Control, Surveillance Coordination Group

1988 - 1990 Member and initial author, workgroup on Data and Surveillance Systems, Year 2000 National Health Objectives

1990 - 1997 Acting editor Morbidity and Mortality Weekly Report (in absence of editor)

1992 - 1997 Chairman, Centers for Disease Control and Prevention, Prevention Effectiveness

Technical Working Group,

1993 - 1995 Member, Task Force on principles for Economic Analysis of Health Care Technology, Leonard Davis Institute, University of Pennsylvania

1993 - 1995 CDC liaison to the US Preventive Services Task Force, Office of Disease

Prevention and Health Promotion

1993 - 1995 CDC liaison to the Panel on Cost Effectiveness in Health and Medicine, Office of Disease Prevention and Health Promotion

1995 - 1996 Member, Advisory Committee, Center for Risk Analysis, Harvard School of

Public Health 3

1995 - 1997 Consultant to NIH Diabetes Prevention Program (Clinical Trial) 1996 Task Force on Technology Assessment of Medical Devices (Washington)

1997 - 2001 Consultant to CDC Task Force on Community Preventive Services 1996 - 1997 Panel on Cost Effectiveness of Screening of Diabetes (CDC) 1998 - 2007 1998-2006 Member, US Preventive Services Task Force (chair methods work

group) 2007 – Consultant, US Preventive Services Task Force

1998 Member Workgroup on Noninfectious Diseases, Global disease Elimination and Eradication as Public Health Strategies

2000-2001 Consultant, Robert Wood Johnson Foundation, Population Health and Scholars

Program

2000-2003 Member, Infectious Diseases Society of America, Practice Guideline Committee

2000- Member, Guide to Community Preventive Services Task Force, CDC (Consultant after 2007)

2001 – 2002 Member, Robert Wood Johnson Foundation Population Health Science and

Policy Visiting and Technical Advisory Committees 2002-2003 Chair, expert panel on Risks and Benefits of Fish Consumption, Harvard Center

for Risk Analysis

2002-2003 Partnership to Promote Healthy Eating and Active Living. Economic Discovery Workshop, Physical Activity Working Group

2000- Board Member, Partnership for Prevention (Council of Advisors, beginning 2009)

2002-2003 Member, Medicare Advisory Committee. Partnership for Prevention 2001- Member, United Health Foundation State Health Rankings Scientific Advisory

Group

2003 - Member, National Commission on Prevention Priorities

2003-2005 Member, Advisory Committee, Project MOVE, CDC

2002-2005Member, Pennsylvania Cardiovascular Health Consortium

2002 – 2009 Member, Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, CDC (chair methods subcommittee)

2006 – 2011 Chair, Secretary’s Advisory Committee on Genetics, Health and Society

(Member 2006-2008, Chair 2008-2011) 2006 Member, Technical Expert Panel, Objective-setting and Framework Process

4

Healthy People 2020 2006 - 2008 Member, Personalized Health Care Work Group, American Health Information

Community, Office of the National Coordinator for Health Information Technology, HHS

2007 -2012 Member, Scientific Advisory Board, Evidence-Based Behavioral Practice 2008 - 2009 Member, Scientific Advisory Committee, National Pharmaceutical Council 2008 Member, Institute of Medicine Committee on State of the USA Health Indicators 2008 - Member, Medicare Evidence Development and Coverage Advisory Committee

(MedCAC), Centers for Medicare and Medicaid Services, HHS 2009 - 2010 Priorities Subcommittee, Secretary’s Advisory Committee on Health Promotion

and Disease Prevention (HP2020) 2009 -2013 Member, TRANSPERS, (Center for Translational and Policy Research on

Personalized Medicine) Reimbursement and Policy Committee, UCSF 2009 - Member, Advisory Board, Center for Comparative Effectiveness of Genomic

Medicine, University of Pennsylvania School of Medicine 2009- 2012 Member, External Stakeholder Advisory Group (ESAG), Center for

Comparative Effectiveness Research in Cancer Genomics project (CANCERGEN), U Washington, SW Oncology Group, Center for Medical Technology Policy

2010 Co-chair, Subcommittee of Secretary’s Advisory Committee on Health

Promotion and Disease Prevention (HP2020) to recommend action steps and evidence to ensure the effective implementation of Healthy People 2020

2010- 2014 Co-editor-in-Chief, Rx for Prevention (Los Angeles County Public Health

Department newsletter for physicians) 2010- Chair Technical Advisory Committee, Adult, California Health Interview

Survey.

2010-2012 Member, Surveillance and Epidemiology Workgroup, Advisory Committee to the Director of CDC

2010 – 2011 Member, Institute of Medicine Committee, Leading Health Indicators for Healthy People 2020

2010-2012 Vice Chair, Committee on Public Health Strategies, Institute of Medicine

2011 Leading Health Indicators Subcommittee, Secretary’s Advisory Committee on

Health Promotion and Disease Prevention (HP2020)

2011- 2014 Member, University of Southern California, Clinical Translational Science Institute (CTSI) Advisory Board

5

2011-2012 Member, Institute of Medicine, Committee on Valuing Community-Based, Non-

Clinical Prevention Policies and Wellness Strategies 2011- Member, USPSTF-Scientific Resource Center Technical Expert Advisory Panel

(TEAP) 2012- Member, Policy Committee, American College of Epidemiology 2012 Member, review panel on economic research in the National Center for

Immunization and Respiratory Diseases (CDC) 2012 Chair, CDC review panel on PRISM (Prevention Impacts Simulation Model) 2012- 2013 Chair, Committee on Quality Measures for the Health People Leading Health

Indicators, Institute of Medicine 2012 Member ASTHO Expert Panel on Improving Health Outcomes in States 2013 - Member, Institute of Medicine Board on Population Health and Public Health

Practice 2013 - Member, National Advisory Committee, the Practical Playbook for Integrating

Public Health and Primary Care. Duke University and the deBeaumont Foundation

2013 - Member, National Advisory Committee, Robert Wood Johnson Foundation

Health and Society Scholars program 2013- Prevention and Cost Advisory Committee (PCAC), Altarum Institute Center for

Sustainable Health Spending (CSHS) 2013- Technical Advisory Group (TAG), Blue Shield Foundation Innovations

Scorekeeper 2013- Member, Institute of Medicine Committee on Core Metrics for Better Health at

Lower Cost 2013- Member, Steering Committee, National Quality Forum, Multistakeholder Input

on a National Priority: Improving Population Health by Working with Communities

2013 Member, Evaluation Committee, Fielding School of Public Health, UCLA

ACADEMIC APPOINTMENTS:

1991 - 1995 Adjunct Professor, Division of International Health, Emory University, School of Public Health

1995 - Adjunct Professor, Department of Health Policy and Management, Emory

University, Rollins School of Public Health

6

1999 - 2007 Adjunct Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, School of Medicine

1999- Adjunct Professor in the Department of Epidemiology, U. No. Carolina School of

Public Health 2013-- Sr. Lecturer (March-June 2013) and Adjunct Professor (July 2013 - ),

Department of Health Policy and Management, Fielding School of Public Health University of California, Los Angeles

2013-- Senior Fellow, Leonard D. Schaeffer Center for Health Policy and Economics,

University of Southern California 2014-- Chair, Technical Expert Panel for Population Health Measures: Assessment and

Design

MEDICAL LICENSE: Pennsylvania (M.D.) California (M.D.) BOARDS: National Boards - passed parts I, II, III Board Certification: Internal Medicine (l977)

Board Certification: Preventive Medicine (1996) SOCIETIES: American College of Physicians American College of Preventive Medicine HONORS: John Harvard Scholarship (Honorary) Fellow, American College of Physicians U.S. Public Health Service Commendation Medal (2) Society of Prospective Medicine Medallion

U.S. Public Health Service Citation U.S. Public Health Service Group Award (3) U.S. Public Health Service Outstanding Service Medal U.S. Public Health Service Meritorious Service Medal U.S. Public Health Service Surgeon General’s Award for Exemplary Service

Fellow, American College of Preventive Medicine Named Fellowship, Steven M. Teutsch Fellowship Fellow, American College of Epidemiology Lifetime Achievement Award, LA County Dept. of Public Health Special Award, Los Angeles County LANGUAGES: Danish - fluent Spanish: fair HOBBIES: Tennis, gardening, reading ADDITIONAL Appalachia - rural health care, 6 weeks, l972 TRAINING: Research: Duke University Medical Center: HL-A linked immune response

genes, 1972 Harvard College: Light effects on porphyrin synthesis in algae, l969-l970 American Management Association Management Course, 1983

7

FOREIGN AFS exchange student, Denmark (l965-l966) EXPERIENCE: London, studying the National Health Service (4 weeks, l973)

Belgrade, Yugoslavia, studying the Yugoslavian Health Care System (l0 weeks, l974) Bangladesh, disaster assessment (3 weeks, 1988) Russia, workshop on surveillance (1 week, 1993)

TEACHING EXPERIENCE: Guest Lecturer U. of Pittsburgh, School of Public Health

Guest Lecturer U. of No. Carolina, School of Public Health Regular Guest Lecturer, Emory University, School of Public Health (MPH 532), 1989-1994 Conduct courses on prevention effectiveness, CDC Kerr White Institute (1997) Nordic Summer Course on Infectious Disease Epidemiology (1 week per year, 1995 - 1997) UCLA 2014

REVIEWER: JAMA Archives of Internal Medicine Annals of Internal Medicine American Journal of Preventive Medicine (Editorial Board) Medical Decision Making (Editorial Board 2003-2006) Diabetes Care Health Affairs

8

DUTIES: l977 - 1979 Epidemic Intelligence Officer, Center for Disease Control. Surveillance of

parasitic diseases in the United States, including surveillance of malaria and publishing of Annual Malaria Surveillance Report; advising on clinical aspects of parasitic diseases; rendering epidemic aid; organizing pilot surveillance for toxoplasmosis. This function requires training in all aspects of parasitic and tropical diseases both within the United States and abroad, and consultation is provided to private physicians and to local, state, national and international health agencies. Parasitic Diseases Division, CDC, has a drug service whose function is to provide investigational drugs for the treatment of tropical diseases. This function requires a detailed knowledge of clinical tropical medicine, therapeutics, and investigational drug procedures, and collaboration with pharmaceutical companies and the Food and Drug Administration.

l979 - 1981 Chief, Kidney Disease Activity. Administer a program to increase the number of

cadaveric kidneys retrieved through training of and providing technical assistance to procurement programs; conduct epidemiologic studies concerning the prevention of kidney disease. Provide consultation to state health departments regarding diabetes control project.

1981 - 1983 Chief, Operational Research, Division of Diabetes Control. Conduct and

coordinate investigations of risk factors for complications of diabetes and methods for improving health services. Conduct special studies, e.g. mortality associated with insulin infusion pumps. Provide technical expertise to the Division and State Diabetes Control Projects. Provided scientific basis for control of major diabetic complications and developed evaluation system for State diabetes control programs.

1983 - 1987 Chief, Technical and Operational Research Branch, Division of Diabetes Control.

As above. Responsible for supervision of professional staff. Provide leadership and programmatic direction regarding scientific aspects of diabetes control.

1987 - 1988 Chief, Epidemiologic Studies Branch. Provide leadership and coordination for

epidemiologic surveillance, with emphasis on developing systems for surveillance of chronic diseases. Supervise staff of medical epidemiologists. Oversee development of software systems for epidemiologic studies and surveillance. Oversee study of major complications of anesthesia.

1988 - 1991 Director, Division of Surveillance and Epidemiologic Studies. Direct the

communication and dissemination of surveillance and other epidemiologic information to facilitate the practice of epidemiology, to prevent and control disease outbreaks, and to improve the practice of public health. Responsible for CDC-wide system for the collection of epidemiologic data from a variety of sources. Oversee the collection, collation, reporting, and dissemination of epidemiologic surveillance data to assure that national morbidity and mortality information is accurate and rapidly available to users to facilitate disease prevention and control. Serve as the principal investigator for major epidemiologic studies; coordinate surveillance-related activities throughout CDC; and provide expert consultation on surveillance methods and practice to government and private agencies in the U.S. and abroad. Develop new

9

approaches to epidemiologic study design, methodology, analysis and surveillance and practice. Responsible for epidemiologic communication with State, local, private, and international agencies.

1991 - 1996 Special Assistant to the Director, EPO. Develop approach to Prevention

Effectiveness for CDC. Co-editor book on surveillance.

1992 - 1996 Chief, Prevention Effectiveness Activity, EPO. Develop a conceptual framework for the assessment of the effectiveness of prevention strategies. Develop training courses for CDC staff on economic analysis, decision analysis, and meta-analysis. Develop guidelines for methods for assessing the effectiveness of prevention strategies. Co-edit book on prevention effectiveness. Provide technical assistance to CDC programs in conducting prevention effectiveness studies. Coordinate assessment of the effectiveness and cost effectiveness of prevention programs. Establish and implement post-doctoral fellowship in prevention effectiveness. Establish and implement urban research centers to evaluate the effectiveness and cost effectiveness of interventions targeted at disadvantaged inner cities.

1996 -1997 Director, Division of Prevention Research and Analytic Methods, EPO. In

addition to activities listed under Prevention Effectiveness Activity, responsible for development of a Guide to Community Prevention Services. Lead the development of behavioral, evaluation, and statistical sciences at CDC.

1997-2000 Senior Director, Outcomes Research and Management, Merck & Co., Inc. Serves

as deputy director for 40-member staff which develops disease management programs, conducts policy analyses and outcomes research.

2000-2007 Group Leader, Customer Liaison Group, ORM, Merck & Co., Inc. Provides

analytic support and leadership to the department as well as primary coordination of disease management and outcomes research to managed care, employers, and other Merck customer segments. Research agenda includes impact of benefit design on health care utilization and outcomes, quality improvement, preventive services, healthy human capital, comparative effectiveness and cost effectiveness.

2006- 2008 Executive Director, US Outcomes Research, Merck & Co, Inc. Oversee

customer-related initiatives related to adherence, disparities, consumerism, benefits design, health policy and health technology assessment

2009 - 2014 Chief Science Officer, Los Angeles County Department of Public Health

January 13, 2015

10

PUBLICATIONS 1. Teutsch SM, Juranek DD, Sulzer A, Dubey JP, Sikes RK: Epidemic toxoplasmosis associated with infected

cats. N Eng J Med 300:695-700, March 29, l979. 2. Teutsch SM, Martone WJ, Brink EW, Potter ME, Eliot G, Hoxsie R, Craven R, Kauffmann AF: Pneumonic

tularemia in Martha's Vineyard. N Eng J Med 30l: 826-828, October ll, l979.

3. Maddison SE, Slemenda SB, Teutsch SM, Walls KW, Kagan IG, Mason WR, Bell F, Smith J: Lymphocyte

proliferative responsiveness in 3l patients after an outbreak of toxoplasmosis. Am J Trop Med & Hyg 28:955-96l, November l979.

4. Teutsch SM: Malaria - an American problem. Internat J Derm l8:575-577, September l979. 5. Center for Disease Control: Malaria Surveillance Annual Summary l977, issued l978, and l978, issued l979

(compiler). 6. Center for Disease Control: Health Information for International Travel l978 (contributor). 7. Center for Disease Control: Health Information for International Travel l979 (contributor). 8. AMA Drug Evaluations, 4th Edition, l979 (consultant). 9. Campbell CC, Chin WC, Collins WE, Teutsch SM, Moss DM: Chloroquine-resistant Plasmodium

falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet 2:ll5l-ll54, l979.

l0. Teutsch SM, Etkind P, Burwell EL, Sato K, Dana MM, Fleishman PR,

Juranek DD: Babesiosis in post-splenectomy hosts. Am J Trop Med & Hyg 29(5): 738-74l, l980. 11. Teutsch SM, Sulzer A, Murray W, Ramsey JE, Juranek DD: Isolation of Toxoplasma gondii from amniotic

fluid - a case report. Obstetrics and Gynecology (Suppl) 55:25-45, l980. l2. Bart KJ, Macon EJ, Humphries AL, Baldwin RJ, Fitch T, Pope RS, Rich MJ, Langford D, Teutsch SM,

Blount JH: Increasing the supply of cadaveric kidneys for transplantation. Transplantation 3l(5):383-387. l3. Dubey JP, Sharma SP, Juranek DD, Sulzer AJ, Teutsch SM: Characterization of Toxoplasma gondii isolates

from an outbreak of toxoplasmosis in Atlanta, Georgia. Am J Vet Res 42:l007-l0ll, l98l. 14. Teutsch SM, Juranek DD. Babesiosis. Ann of Intern Med 95:241, 1981. 15. Akstein RB, Wilson LA, Teutsch SM: Acquired Toxoplasmosis. Ophthalmology 89(12):1299-1302,

December 1982. 16. Herman WH, Teutsch SM, Sepe SJ, Sinnock P, and Klein R: An approach to the prevention of blindness in

diabetes. Diabetes Care 6:608-13, 1983. 17. Teutsch SM, Herman WH. Dwyer DM, Lane JM: Mortality among diabetic patients using continuous

subcutaneous insulin infusion pumps. N Eng J Med 310:361-368, February 1984.

11

18. Rettig B, Teutsch SM: The incidence of end-stage renal disease in Type I and Type II diabetes mellitus. Diabetic Nephropathy 3:26-27, February 1984.

19. Teutsch SM, Herman WH, Lane JM, Dwyer DM: Continuous Subcutaneous Insulin-Infusion Pumps. N Eng

J Med 311:1052-1053, October 1984, (Letter). 20. Herman WH, Teutsch SM: Kidney Diseases Associated with Diabetes Mellitus. National Diabetes Data

Group. Diabetes Data - Compiled 1984, Chapter XIV:1-31, August, 1985. 21. Herman WH, Teutsch SM: Renal Disorders associated with Diabetes Mellitus. in Friedman EA and

L'Esperance, Diabetic Renal-Retinal Syndrome, Volume 3, Grune and Stratton, 1986 22. Teutsch SM, Herman WH: Mortality Among Patients Using Continuous Subcutaneous Insulin Infusion

Pumps. Clinical Diabetes 3:34-35, March/April, 1985. 23. Teutsch SM, Herman WH: Surveillance of Acute Complications of New Therapies. Diabetes Care 8

(Suppl 1):51-53, 1985. 24. Herman WH, Teutsch SM, Geiss LS: Closing the gap: The problem of Diabetes Mellitus in the United

States. The Carter Center of Emory University, Atlanta, GA. Diabetes Care 8:391-406, July-August, 1985. 25. Sepe SJ, Connell FA, Geiss LS, Teutsch SM: Gestational Diabetes:

Incidence, Maternal Characteristics, and Perinatal Outcome. Diabetes 34 (Suppl. 2): 13-16, June, 1985. 26. Geiss LG, Herman WH, Teutsch, SM: Diabetes and Renal Mortality in the United States. Am J Public

Health 75:1325-1326, November, 1985. 27. Rettig BA, Klein DK, Teutsch SM, Langford D: A Case Study of Diabetic End-stage Renal Disease in

Nebraska. Nebraska Medical Journal 70:370, October, 1985. 28. Braveman P, Showstack J, Browner W, Selby J, Teutsch SM, Sepe S. Evaluating Outcomes of Pregnancy in

Women with Diabetes: Epidemiologic Considerations and Recommended Indicators. Diabetes Care 1988;11:281-287.

29. Bild D, Teutsch SM: The Control of Hypertension in Persons with Diabetes: a Public Health Approach.

Public Health Reports 1987;102:522-529. 30. Herman WH, Teutsch SM, Geiss LS. Diabetes Mellitus. In Amler RW and Dull HB, eds. Closing the Gap:

The burden of unnecessary illness. Am. J. Prev. Med. Oxford University Press, 1987. 31. Bild D, Geiss L, Teutsch SM, et.al.: Sentinel Health Events Surveillance in Diabetes. J Clin Epidemiol

1988;41:10:999-1006. 32. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM,

Bennett PH: Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988;31:730-736.

33. Sepe JS, Teutsch SM: Epidemiology of Renal Involvement in Diabetes Mellitus, pp. 17-23: in Mogensen

CE, ed., The Kidney and Hypertension in Diabetes Mellitus, Martinus Nijhoff Publishing, 1988. 34. Teutsch SM, Newman J, Eggers P: The Problem of Diabetic Renal Failure in the United States, an

Overview. Am J Kidney Dis Vol. XIII, No. 1:11-13, January, 1989. 12

35. Hahn RA, Teutsch SM, Rothenberg RB: Chronic Disease Reports in the Morbidity and Mortality Weekly

Report (MMWR). Centers for Disease Control, Vol. 38, No. S-1, February, 1989 36. O'Brien TR, Flanders WD, Decoufle P, Boyle CA, DeStefano F, Teutsch SM: Are Racial Differences in the

Prevalence of Diabetes in Adults Explained by Differences in Obesity? JAMA 1989;262:1485-1488. 37. Birkhead G, Attaway NJ, Strunk RC, Townsend MC, Teutsch SM: Investigation of a Cluster of Deaths of

Adolescents From Asthma: Evidence Implicating Inadequate Treatment and Poor Patient Adherence with Medications. J Allergy Clin Immunol 1989;84:484-91.

38. Otten MW, Teutsch SM, Williamson DF, Marks JS: The Effect of Known Risk Factors on the Excess

Mortality of Black Adults in the United States. JAMA 1990;263:845-850. 39. Hahn RA, Teutsch SM, Rothenberg RB, Marks JS: Excess Deaths from Nine Chronic Diseases in the

United States, 1986. JAMA 1990;264:2654-2659. 40. Hahn RA, Teutsch SM: Excess Deaths from Nine Chronic Diseases in the United States, 1986 (Letter to the

Editor) JAMA 1991;265:1111-1112. 41. Teutsch SM, Berkelman RL, Toomey K, Vogt R: Reporting for Disease Control Activities, Am J Public

Health 1991;81:932. 42. Braun M, Teutsch SM: Screening for Prostatic Cancer (letter), N Eng J Med 1991;325:964. 43. Hahn RA, Mulinare J, and Teutsch SM: Inconsistencies in Coding of Race and Ethnicity between Birth and

Death in US Infants: A new look at infant mortality, 1983 through 1985, JAMA 1992;267:259-263. 44. Teutsch SM: A Framework for Assessing the Effectiveness of Disease and Injury Prevention. MMWR

Recommendations and Reports 1992;Vol.41:No.RR-3;i-iv and 1-12. 45. Hahn RA, Mulinare J, and Teutsch SM: Inconsistent Coding of Race and Ethnicity in Infants (letter), JAMA

1992;267:3152. 46. Sienko DG, Hahn RA, Mills EM, Yoon-DeLong V, Ciesielski CA, Williamson GD, Teutsch S, Klenn PJ,

Berkelman R. Mammography Use and Outcomes in a Community: The Greater Lansing Area Mammography Study. Cancer 1993; 71:1801-9.

47. Teutsch SM, Churchill ER, editors: Principles and Practice of Public Health Surveillance, Oxford

University Press, 1994 48. Teutsch SM: Considerations in Planning a Surveillance System in Teutsch SM, Churchill ER, editors:

Principles and Practice of Public Health Surveillance, Oxford University Press, 1994 49. Teutsch SM, Luce BR, Lowder DO: CDC Hones in on Prevention. HMO Magazine 47-48, July/August

1993. 50. Manninen DL, Dasbach EJ, Dong FB, Aubert R, Teutsch SM, Herman WH. Economic evaluations of

strategies for preventing renal disease in non-insulin dependent diabetes mellitus. in Mogensen CE, Standl E, Diabetes Forum Series, Volume VII. WG De Gruyter. Berlin, New York, 1994.

51. Haddix A, Dasbach E, Teutsch S. Economic analysis in diabetes. in Mogensen CE and Standl E, Diabetes 13

Forum Series, Research Methodologies in Human Diabetes, Volume 5, Part 1; Walter de Gruyter, Berlin, 1994; 405-416.

52. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM. Is race related to glycemic control? An

assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol 47(10):1181-89,1994.

53. Gold M, Teutsch S, McCoy K, Siegel J, et al. For a healthy nation: returns on investment in public health.

US Department of Health and Human Services, US Public Health Service pp 1-49., 1994 54. Haddix A, Teutsch SM, Shaffer P, Dunet D, Churchill E, eds. A Practical Guide to Prevention

Effectiveness: Decision and Economic Analysis. Centers for Disease Control and Prevention, 1994. 55. Roper WL, Thacker SB, Teutsch SM. Translating science into practice in child day-care settings.

Pediatrics 1994; 6(Suppl):1112-4. 56. Hahn RA, Eaker E, Barker ND, Teutsch SM, Sosniak W, Krieger N. Poverty and Death in the United

States--1973 and 1991. Epidemiology 1995;6:490-497. Followup letter: Epidemiology 1996;7:453-454.

57. Smith JC, Haddix AC, Teutsch SM, Glass RI. Cost-effectiveness analysis of a rotavirus immunization

program for the United States. Pediatrics 1995;96:609-615. 58. Teutsch SM, Thacker SB. Planning a Public Health Surveillance System. Epidemiological Bulletin, Pan

American Health Organization 1995; 16:1-6. Also in Spanish, Planificación de un sistema de vigilancia in salud pública. Boletín Epidemiológoco. Organizacion Panamericana de la Salud 1995;16:1-6.

59. Choi HW, Breman JG, Teutsch SM, Liu S, Hightower AW, Sexton JD. The Effectiveness of insecticide-

impregnated bed nets in reducing cases of clinical malaria: A meta-analysis of published results. Am J Trop Med Hyg 1995;52:377-382.

60. Haddix A, Teutsch SM, Shaffer PS, Dunet D,. Prevention Effectiveness: A Guide to Decision Analysis and

Economic Evaluation. Oxford University Press, New York, 1996. Chapters: Teutsch SM, Harris JR. Chapter 1. Introduction

Teutsch SM, Haddix AC. Chapter 3. Decision Analysis for Public Health

Dasbach E, Teutsch SM. Chapter 9. Cost-Utility Analysis

61. Gorsky R, Teutsch SM. Assesing the effectiveness of disease and injury prevention: costs and

consequences. MMWR RR-10:1-10, August 18, 1995. 62. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL. Trends in

Infectious Diseases Mortality in the United States. JAMA 1996;275:189-193. 63 Gessner BD, Teutsch SM, Shaffer PA. A cost-effectiveness evaluation of newborn hemoglobinopathy

screening from the perspective of state health care systems. Early Human Development 1996; 45:257-275. 64. Teutsch SM, Steindel SJ. Worshop 7: Laboratory-focused health systems research. Workshop summary.

Proceedings of meeting “Frontiers in Laboratory Science” CDC. 14

65. Smith PS, Teutsch SM, Shaffer PA, Rolka H, Evatt B. Episodic versus prophylactic Infusions for Hemophilia A: A Cost-Effectiveness Analysis. J Pediatr 1996;129:424-31.

66. Teutsch, SM. A framework for reducing the burden of cardiovascular disease. in Talley JD, Mauldin PD,

Becker ER, eds. Cost-effective Diagnosis and Treatment of Coronary Artery Disease. Williams and Wilkins, 1997. 33-38.

67. Friede A, O’Carroll PW, Nicola RM, Oberle MW, Teutsch SM, eds. CDC Prevention Guidelines: A Guide

to Action. Williams and Wilkins, Baltimore, 1997. 68. Qualls NL, Teutsch SM. The role of prevention effectiveness in the development, implementation, and

evaluation of public health prevention strategies. Current Issues in Public Health, 1996 2:165-169. 69. Gold MR, McCoy KI, Teutsch S, Haddix AC. Assessing outcomes in population health: moving the field

forward. Am J Prev Med 1997 13:3-5. 70. Teutsch SM. Editorial note: Public health focus: effectiveness of disease and injury prevention. CDC

MMWR 1997;46(4):73-77. 71. Truman BI, Teutsch SM. Chapter 7. Screening in the Community. In: Brownson RC and Petitti DB.

Applied Epidemiology--Theory to Practice. Oxford University Press, New York, 1998. 72. Williamson DF, Venkat Narayan KM, Teutsch SM. The economic impact of obesity in the United States:

Whither? Obesity Research 1998;6(2):173-176. 73. Hahn RA, Teutsch SM, Franks AL, Chang M, Lloyd EE. The prevalence of risk factors among women in

the United States by race and age, 1992-1994: opportunities for primary and secondary prevention. J Am Med Womens Assoc. 1998;53(2):96-104,107.

74. Stroup DF, Teutsch SM. Eds., Statistics in Public Health: Quantitative Approaches to Public Health

Problems. Oxford University Press, New York, 1998. Chapter 6. Meltzer M, Teutsch SM. Setting Priorities for Health Needs and Managing Resources. 75. Becker ER, Principe K, Adams EK, Teutsch SM. Returns on investment in public health. Effect of public

health expenditures on infant health, 1983-1990. J Health Care Financ 1998;25(1):5-18. 76. Ford ES, Kelly AE, Teutsch SM, Thacker SB, Garbe PL. Radon and lung cancer: a cost effectiveness

analysis. Am. J. Public Health 1999;89:351-357 77. Grosse SD, Teutsch SM. Genetics and Prevention Effectiveness in Khoury MJ, Burke W, Thomson EJ.

Genetics and Public Health in the 21st Century, Oxford University Press 2000, Chapter 18 329-360. 78. CDC Diabetes Cost-Effectiveness Study Group. Screening for type 2 diabetes: Is it cost-effective? JAMA

1998;280:1757-1763 79. Simonsen L, Conn LA, Pinner RW, Teutsch S. Trends in Infectious Disease Hospitalizations in the United

States, 1980-1994. Arch Intern Med. 1998;158:1923-1928. 80. Teutsch SM, Murray JF. Dissecting Cost Effectiveness Analysis for Preventive Interventions: A Guide for

Decision Makers. Am J. Managed Care. 1999;5:301-305 15

81. Wang LY, Haddix AC, Teutsch SM, Caldwell B. The role of resource allocation models in selecting clinical preventive services. Am. J. Managed Care. 1999;5:445-454

82. Messonier ML, Corso PS, Teutsch SM, Haddix AC, Harris, JR. An ounce of prevention . . . what are the

returns? Am J Prev Med 1999;16:248-263 83. Briss PA, Zaza S, Pappaioanou M, Fielding J, Wright-De Agüero L, Truman BI, Hopkins DP, Mullen PD,

Thompson RS, Woolf SH, Carande-Kulis VG, Anderson LM, Hinman AR, McQueen DV, Teutsch SM, Harris JR and the Task Force on Community Preventive Services. Developing an Evidence-Based Guide to Community Preventive Services —Methods. Am. J Prev Med 2000;18(1S):35-43.

84. Carande-Kulis VG, Maciosek MV, Briss PA, Teutsch SM, Zaza S, Truman BI, Messonnier ML,

Pappaioanou M, Harris JR, Fielding J, and The Task Force on Community Preventive Services. Methods for Systematic Reviews of Economic Evaluations for the Guide to Community Preventive Services. Am J Prev Med 2000;18(1S):75-91.

85. Zaza S, Wright-DeAguero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH, Sosin DM, Anderson L,

Carande-Kulis VG, Teutsch SM, Pappaioanou M and the Task Force on Community Preventive Services. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Am J Prev Med 2000;18(1S):44-74.

86. Teutsch SM. Book Review: Epidemiologic Methods for Public Health Policy by Robert Spasoff. The

Epidemiology Monitor 1999;20:9-10 87. Stone PW, Teutsch SM, Richard H. Chapman, Bell C, Goldie SJ, Neumann PJ. Cost-Utility Analyses Of

Clinical Prevention Services: Published ratios, 1976–1997. Am J Prev Med 2000;19:15-23 88. Teutsch SM. Book Review: Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods

for Quantitative Synthesis in Medicine, Second Edition by Diana Petitti in The Epidemiology Monitor 2000;3:8,10.

89. Berger ML, Teutsch SM. Understanding cost-effectiveness analysis. Prev Med in Mgd Care 2000;1:51-58. 90. Teutsch SM, Churchill ER, editors: Principles and Practice of Public Health Surveillance, Second Edition,

New York: Oxford University Press; 2000. Teutsch SM. Chapter 2. Considerations in Planning a Surveillance System. 91. Guico-Pabia C; Murray JF, Teutsch SM; Wertheimer SM; Berger ML. Indirect Cost of Ischemic Heart

Disease to Employers. Am J Mgd Care 2001;7:27-34. 92. Alexander CM, Landsman PB, Teutsch SM. Diabetes Mellitus, Impaired Fasting Glucose, Atherosclerotic

Risk Factors, and Prevalence of Coronary Heart Disease. Am J Cardiology 2000;86:897-902. 93. Dasbach E, Davies G, Teutsch S. The Burden of Aspergillosis-Related Hospitalizations in the United States.

Clinical Infectious Diseases 2000;31:1524-1528. 94. Becker ER, Teutsch SM. State maternal and child expenditures and low birthweight infants: a descriptive

analysis. J Health Care Financ 2000;27:1-10. 95. Russell LB, Teutsch SM, Kumar R, Dey A, Milan E. Preventable Smoking and Exercise-related Hospital

Admissions: A Model based on the NHEFS. Am J Prev Med 2001;20:26-34.

16

96. Vicari RM, Wan GJ, Aura AM, Alexander CM, Markson LE, Teutsch SM, for the Simvastatin Combined Hyperlipidemia Registry Group. Use Of Simvastatin Treatment In Patients With Combined Hyperlipidemia In Clinical Practice. Arch Fam Med. 2000; 9:898-905

97. Chang M, Hahn RA, Teutsch SM, Hutwagner L. Multiple Risk Factors and Population Attributable Risk for

Ischemic Heart Disease Mortality in the United States, 1971 –1992. Journal of Clinical Epidemiology 2001;54:634-644.

98. Lin S, Schranz J, Teutsch SM. Aspergillosis Case-Fatality Rate: Systematic Review of the Literature.

Clinical Infectious Diseases 2001;32:358-66. 99. Teutsch SM. Is an Ounce of Prevention Always Worth a Pound of Cure? Western Journal of Medicine

2001;174:84 100. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D for the Methods Work

Group, Third US Preventive Services Task Force. Current Methods of the U.S. Preventive Services Task Force: A Review of the Process. Am J Prev Med 2001;20(3S):21-35.

101. Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Mandelblatt JS for the Cost Work Group of the

Third US Preventive Services Task Force. The Art and Science of Incorporating Cost Effectiveness into Evidence-Based Recommendations for Clinical Preventive Services. Am J Prev Med 2001;20(3S):36-43.

102. Pignone MP, Phillips CJ, Atkins D, Teutsch SM, Mulrow CD. Lohr KN. Screening and Treating Adults for

Lipid Disorders. Am J Prev Med. 2001;20(3S): 77-89 103. Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH,

Haddix A. Priorities Among Recommended Clinical Preventive Services. Am J Prev Med 2001;21:1-9 104. Maciosek MV, Coffield AB, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH,

Haddix A. Methods for Priority Setting Among Clinical Preventive Services. Am J Prev Med 2001:21:10-19

105. Hahn RA, Teutsch SM, Franks AL, Chang M-H, Lloyd EE. The prevalence of risk factors among women in

the United States. In: Conrad P., ed. The Sociology of Health and Illness: Critical Perspectives, 6th edition. Worth Publishers, 2001.

106. Guico-Pabia CJ, Murray JF, Berger ML, Teutsch SM, Indirect Cost of Ischemic Heart Disease to Employers

(Letter to the Editor). Am J Mgd Care 2001;7:330-1 107. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus and prevalence of CHD. Cardiology Review

2001;18:34-38. 108. Teutsch SM. A framework for outcomes research in cancer: Response to Carolyn Clancy. Medical Care

2002;40 (6) Supplement III101-103. 109. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in Snow, Vincenza,

ed. Screening for Disease: Prevention in Primary Care. American College of Physicians, Philadelphia, 2004.

110. Haddix A, Teutsch SM, Corso PS. Prevention Effectiveness: A Guide to Decision Analysis and Economic

Evaluation, 2nd ed. Oxford University Press, New York, 2003 . 111. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD Postmenopausal Hormone Replacement 17

Therapy: Systematic Evidence Review of Benefits and Harms for the Primary Prevention of Chronic Conditions. JAMA 2002;288:872-881. Letter to the editor response JAMA 2003;289:44-45.

112. Eden KB, Orleans CT, Mulrow CD, Pender NJ, Teutsch SM. Counseling by Clinicians: Does It Improve

Physical Activity? A summary of the evidence for the US Preventive Services Task Force. Ann Int Med 2002;137:208-215

113. Moxey ED, O’Connor JP, Novielli KD, Teutsch SM, Nash DB. Prescription Drug Use in the Elderly: A

Descriptive Analysis. Health Care Financing Review 2003;24:127-141. 114. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for Colorectal Cancer in Adults at

Average Risk: Summary of the Evidence for the U.S. Preventive Services Task Force. Annals Int Med 2002;137:132-141.

115. Harris JR, Zaza S, Teutsch SM. Chapter 17: Prevention Effectiveness. In Scutchfield FD and Keck W, eds.

Principles of Public Health Practice, 2nd Ed. Delmar. 2003: 116. Lubetkin EI, Sofaer S, Gold M, Berger ML, Murray JF, Teutsch SM. Performance Measurement to

Maximize Individual and Population Health: Is That Where We Are Going? Am J Publ Hlth 2003;93(3): 406-411

117. Teutsch S. The cost of preventing diabetes: What do we know and what do we need to know? (editorial).

Diabetes Care 2003;26:238-239. 118. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes and

prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214.

119. Teutsch S. The Cost Effectiveness of Preventing Diabetes (editorial). Diabetes Care 2003;26:2693-4.

. 120. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu,AL, Atkins D,Klein J,Helfand M for the Cost Work Group

of the U.S. Preventive Services Task Force. The Cost-Effectiveness of Screening Mammography beyond Age 65 Years: A Systematic Review for the U.S. Preventive Services Task Force. Ann Int Med 2003;139:835-842

121. Humphrey L, Nelson HD, Chan BKS, Nygren P, Allan J, and Teutsch S. Relationship Between Hormone

Replacement Therapy, Socioeconomic Status, and Coronary Heart Disease (l) JAMA 2003;289: 45 122. Davies GM, Dasbach EJ, Teutsch S. The Burden of Appendicitis-Related Hospitalizations in the United

States in 1997. Surgical Infections Vol 5, No 2, 2004:5(2): 160-5.

123. Sheridan SL, Harris RP, Woolf SH and Shared Decision-Making Workgroup of the U.S. Preventive Services Task Force. Shared decision making about screening and chemoprevention: A suggested approach from the U.S. Preventive Services Task Force. Am. J. Prev. Med.2004;26:56-66.

124. Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, Corso P, Hutchinson AB, Hiatt R, Kerner J, George P, White C, Gandhi N, Saraiya M, Breslow R, Isham G, Teutsch SM, Hinman AR, Lawrence R and Task Force on Community Preventive Services. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004;26:67-80.

125. Contributor to: Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, eds. Health Care Cost, Quality, and Outcomes. ISPOR Book of Terms. Internatl. Soc for Pharmacoecon and Outcomes Resarch, Lawrenceville, NJ. 2003

18

126. Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM. Pharmacy Benefits and the Use of Drugs by the Chronically Ill. JAMA 2004;291:2319-2327

127. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computer tomography: An update for the US Preventive Services Task Force. Annals Int Med 2004;140;740-753.

128. Martin DC, Berger ML, Anstatt DT, Wofford J, Warfel D, Turpin RS, Cannuscio CC, Teutsch SM, Mansheim BJ. A Randomized Controlled Open Trial of Population-based Disease and Case Management in a Medicare Plus Choice HMO. Preventing Chronic Disease 2004;1 (October) http://www.cdc.gov/pcd/issues/2004/oct/04_0015.htm

129. Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 2004;25:628-633.

130. O’Connor PJ, Gray RJ, Maciosek MV, Fillbrandt KM, DeFor TA, Alexander CM, Weiss TW, Teutsch SM. Cholesterol levels and statin. use in heart disease patients: Can primary care get the job done? Preventing Chr Dis [serial online] Vol 2, 2005 Jul Available from: URL: http://www.cdc.gov/pcd/issues/2005/ jul/04_0146.htm.)

131. Teutsch SM, Berger ML, Weinstein M. Comparative Effectiveness: Asking the Right Question. Choosing the Right Method. Health Affairs 2005;24:128-132.

132. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie S, Wilcox S, Harrison LH, Seabberg EC, Hajjeh RA, Teutsch SM. Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance. Infection Control and Hosp Epid 2005:26:540-547

133. Alexander CM, Landsman PB, Nag S, Teutsch SM, Haffner SM. CHD Prevalence in Americans Age 50 years and Older Using NCEP and WHO Definitions of Metabolic Syndrome. Clinical Research and Regulatory Affairs 2004; 21:179-190.

134. Pignone M, Saha S, Hoerger T, Lohr KN, Teutsch S, Mandelblatt J. Challenges and Recommendations in Systematic Reviews: Economic Analyses. Ann Int Med 2005;142:1073-1079.

135. Berger M, Teutsch S. Commentary: Cost Effectiveness Analysis: From Science to Application. Medical Care 2005;43:II-49 – II-53.

136. Teutsch SM, Briss PA. Editorial. Spanning the boundary between clinics and communities to address overweight and obesity in children. Pediatrics. 2005; 116(1):240-241.

137. Moyer VA, Klein JD, Ockene JK, Teutsch SM, Johnson MS, Allan JD; Childhood Obesity Working Group, US Preventive Services Task Force. Screening for overweight in children and adolescents: where is the evidence? A commentary by the childhood obesity working group of the US Preventive Services Task Force. Pediatrics. 2005; 116:235-8.

138. Anderson LM, Brownson RC, Fullilove MT, Teutsch SM, Novick LF, Fielding J, Land GH. Evidence-based public health policy and practice: Promises and limits. Am J Prev Med 2005;28(5S):226-230.

139. Cohen JT, Bellinger DC, Connor WE, Kris-Etherton PM, Lawrence RS, Savitz DA, Shaywitz BA, Teutsch SM, Gray GM. A quantitative risk-benefit analysis of changes in population fish consumption Am J Prev Med 2005;29:325-334.

140. Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, Konig A, Lawrence RS, Savitz DA, Teutsch SM. A quantitative analysis of fish consumption and stroke. Am J Prev Med 2005;29:347-352.

141. Konig A, Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, Lawrence RS, Savitz DA, Teutsch SM. A quantitative analysis of fish consumption and coronary heat disease mortality. Am J Prev Med 2005:29:335-346.

142. Teutsch S, Cohen JT. Health trade-offs from policies to alter fish consumption. Am J Prev Med 2005:29:324.

19

143. Teutsch S, Berger M. Evidence Synthesis and Evidence-Based Decision Making: Related, But Distinct Processes (editorial). Med Decision Making 2005;25:487-9

144. Teutsch S, Berger, M. Misaligned Incentives in America’s Health: Who’s Minding the Store? (editorial). Annals Fam Med 2005;3:485-487.

145. Landsman PB, Yu W, Liu XF, Teutsch SM, Berger ML. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care 2005;11;621-8.

146. Neumann PJ, Lin P, Greenberg D, Berger ML, Teutsch SM, Mansley E, Weinstein MC, Rosen AB. Do drug formulary policies reflect evidence of value? Am J Manag Care 2006;12;30-36.

147. Teutsch S. Preventing diabetes: The time is now. Diabetes Care 2006;29(6):1447-8.

148. Teutsch S. Cost Effectiveness of Prevention. MedScape, 2006 http://www.medscape.com/viewarticle/540199

149. McPheeters ML, Briss P, Teutsch SM, Truman B. Systematic reviews in public health. In Brownson RC, Petitti DB. Applied Epidemiology. Theory to Practice 2nd Edition. Oxford University Press. New York, 2006.

150. Grosse SD, Teutsch SM, Haddix AC. Lessons from Cost-Effectiveness Research for United States Public Health Policy. Annu Rev Public Health 2007;28:365-391.

151. Ockene JK, Edgerton EA, Teutsch SM, Marion LN, Miller T, Genevro JL, Loveland-Cherry CJ, Fielding JE,

Briss PA. Integrating evidence-based clinical and community strategies to improve health. Am J Prev Med 2007;32:244-252.

152. Teutsch S. Public Health Surveillance. in Boslaugh S., ed. Encyclopedia of Epidemiology. Sage, 2007 153. Mansley EC, Elbasha EH,. Teutsch SM, Berger ML. The Decision to Conduct a Head-to-Head Comparative

Trial: A Game-Theoretic Analysis. Medical Decision Making 2007;27:364-379. 154. Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch SM, Whitlock E, for the U.S. Preventive Services

Task Force Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development. Ann Intern Med 2007;147:117-22

155. Huang H-Y, Teutsch S, Bass E. Antioxidants and mortality (letter to the editor). JAMA 2007;298:400-401. 156. Teutsch S. The evidence for evidence-based public health. J Public Health Manag Pract 2008;14(2):92-

93. 157. Moyer, VA, Calonge N, Teutsch S, Botkin JR on behalf of the U.S. Preventive Services Task Force. What

Is the Role for Evidence-based Decision Making in Expanded Newborn Screening Policy? Hastings Center Report, 2008;38(No. 3):32-39

158. Nicholson S, Pauly MV, Wu AYJ, Murray J, Teutsch SM, Berger. Getting Real Performance Out of Pay-

For-Performance. Milbank Quarterly 2008;86:435-457. 159. Greene J, Hibbard J, Murray JF, Teutsch SM, Berger ML. The impact of consumer-directed health plans on

prescription drug use. Health Affairs 2008;27:1111-1119. 160. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg

A on behalf of the EGAPP Working Group. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: Methods of the EGAPP Working Group. Genetics in Medicine 2009;11:3-14.

20

Also published as Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg A.. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: Methods of the EGAPP Working Group. in Khoury M, Bedrosian SR, Gwinn M, Higgins JPT, Ioannidis JPA, Little J, eds. Human Genome Epidemiology, 2nd edition, Chapter 23. Oxford University Press, New York. 2010; 458-481.

161. Ferreira-Gonzalez A, Teutsch S, Williams, Sylvia MS,,Au S, FitzGerald K, Miller P, Fomous C, on behalf of

the members of the Secretary’s Advisory Committee on Genetics, Health, and Society. U.S. System of Oversight for Genetic Testing: A Report from the Secretary’s Advisory Committee on Genetics, Health, and Society. Personalized Medicine 2008;5:521-528.

162. Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE,

Heath G, Kohl HW III, Teutsch S, Cawley J, Lee IM, West L, Buchner DM. Cost Effectiveness of Community-Based Physical Activity Interventions? Am J Prev Med 2008;35:578-588.

163. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T on behalf of the U.S. Preventive Services Task Force. Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence. Ann Intern Med 2009;150:199-205.

164. Khoury MJ, Berg A, Coates R, Evans J, Teutsch SM, Bradley LA. The evidence dilemma in genomic medicine. Health Aff (Millwood). 2008;27:1600-11.

165. Teutsch SM, Fielding JE. Programs Deliver Innovative Clinical Preventive Services. AHRQ Health Care

Innovations Exchange. April 2009. http://www.innovations.ahrq.gov/content.aspx?id=2377&tab=2

166. Fielding JE, Teutsch SM. Integrating Clinical Care and Community Health: Delivering Health. JAMA 2009;302(3):317-319.

167. Moyer VA, Calonge N, Teutsch SM, Botkin JR on behalf of the US Preventive Services Task Force. What is the role for evidence-based decision making in expanded newborn screening. pp. 295-211. in Baily MA, Murray TH, Ethics and Newborn Genetic Screening: New Technologies, New Challenges. Johns Hopkins University Press, 2009.

168. Khoury MJ, McBride C, Schully SD, Ioannidis JPA, Feero WG, Janssens ACJW, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, DuRoss A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher J, Hsu A, Hudson KL, Kardia SLR, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts S, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke A, Witte JS, Xu J. The Scientific Foundation for Personal Genomics: Recommendations from an NIH-CDC Disease Control and Prevention Multidisciplinary Workshop. Genetics in Medicine 2009;11(8):.

169. Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Mushlin AI, Teutsch SM, Kern LM. Development and Validation of a self-assessment score for diabetes risk. Ann Int Med 2009;151:775-783.

170. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Comparing the USPSTF and GRADE Approaches to Recommendations (Response to letter). Ann Int Med 2009;151:364.

171. Fogleman S, Rangan C, Kennedy J, Santos M, Kim M, Reporter R, Teutsch SM, Fielding JE, MD, Diamond D. Inadvertent Ingestion of Marijuana --- Los Angeles, California, 2009. MMWR 2009;58(34):947-950.

21

172. Khoury MJ, Rich EC, Randhawa G, Teutsch SM, Niederhuber J. Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine. Genet Med. 2009 Oct;11(10):707-11.

173. Botkin JR, Teutsch, Kaye CI, Hayes M, Haddow JE, Bradley Szegda K, and Dotson WD on behalf of the

EGAPP Working Group. Outcomes of Interest in Evidence-Based Evaluations of Genetic Tests. Genetics in Medicine 12(4):228-235, April 2010.

174. Teutsch, SM. Generating Evidence for Decision Making: Does the Type of Decision Being Made Influence The Evidence Needed? In Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary, Institute of Medicine 2009, Washington, DC.

175. Fielding J, Teutsch S, Breslow L. A Framework for Public Health in the United States. Public Health Reviews 2010:32(1);174-189. http://www.publichealthreviews.eu/upload/pdf_files/7/10_Framework.pdf

176. Fielding J, Teutsch S. Skin cancer prevention: Sunnyside up or scrambled? JNCI 2010;102(7):445-447.- 177. Teutsch SM, Fielding JE. Closing the Gap in Clinical Preventive Services. Am J Prev Med 2010;38(6):684-

685.

178. Lee LM, Teutsch SM, Thacker SB, and St. Louis ME, eds. Principles and Practice of Public Health Surveillance. Third Edition. Oxford University Press, 2010

179. Teutsch SM, Fielding JE. Applying Comparative Effectiveness Research to Public and Population Health Initiatives. Health Affairs 2011;30(2):349-355. http://content.healthaffairs.org/content/30/2/349.full.html

180. Meeker D, Joyce G, Malkin J, Haddix A, Teutsch S, Goldman D. Coverage and Preventive Screening. Health Services Research 2011 Feb;46(1 Pt 1):173-84.

181. Kuo T, DelaCruz H, Redelings M, Smith LV, Reporter R, Simon PA, Fielding JE, Teutsch SM. Use of a self-assessment questionnaire for food safety in the home kitchen – Los Angeles, CA, 2006-2008. MMWR 2010:59(34):1098-1101.

182. Fielding JE, Teutsch SM. An Opportunity Map for Social Investment in Health. JAMA 2011 (May 25, no. 20);305:2110-2111. http://jama.ama-assn.org/content/305/20/2110.short

183. Teutsch SM, Fielding JE. Comparative Effectiveness. Looking Under the Lamppost. JAMA 2011 (June 1 no. 21)305: 225-226.

184. Cui Y, Baldwin SB; Lightstone AS, Shih M, Yu H ; Teutsch S. Small Area Estimates Reveal High Cigarette Smoking Prevalence in Low-Income Cities of Los Angeles County. J Urban Health 2012;89(3):397-406.

185. Fielding JE, Koh H, Teutsch S. Health Reform and Healthy People. Am J Publ Health 2012;102(1):30-33.

186. Fielding JE, Breslow L, Teutsch SM. Chapter 22. Public Health and Clinical Care. in Kominski G., ed. Changing the U.S. Health Care System: Key Issues in Health Services Policy and Management, 4th edition. Jossey-Bass, San Francisco, 2014.

187. Teutsch S, Rechel B. Ethics of Resource Allocation and Rationing Medical Care in a Time of Fiscal Constraint – US and Europe. Public Health Reviews 2012; 34(1): 227-236. http://www.publichealthreviews.eu/upload/pdf_files/11/00_Teutsch.pdf (accessed October, 2012)

22

188. Teutsch SM, Baciu AB, Mays GP, Getzen TE, Mincer-Hansen M, Geller A. Wiser Investment for a Healthier Future. J Public Health Management Practice. 2012;18(4):295-298. (http://journals.lww.com/jphmp/Fulltext/2012/07000/Wiser_Investment_for_a_Healthier_Future.1.aspx#)

189. Teutsch SM, Fielding JE. Rediscovering the Reach of Core Public Health. Ann Rev Publ Health 2013;34:287-299.

190. Fielding JE, Teutsch SM, eds., Caldwell S, Mging Ed. Public Health Practice, What Works. Oxford University Press, New York, 2013.

191. Teutsch S. Programs and Policies That Work: How Evidence Can Drive Action. in Fielding JE, Teutsch SM, eds., Caldwell S, Mging Ed. Public Health Practice, What Works. Oxford University Press, New York, 2013

192. Fielding JE, Teutsch SM. So What? A Framework for Assessing the Potential Impact of Intervention Research. Prev Chronic Dis 2013;10:120160. DOI: http://dx.doi.org/10.5888/pcd10.120160

193. McCullough JM, Zimmerman FJ, Fielding JE, Teutsch SM. A Health Dividend for America: The Opportunity Cost of Excess Healthcare Expenditures in the United States. Am J Prev Med 2012;43(6):650-654. http://www.ajpmonline.org/webfiles/images/journals/amepre/AMEPRE_43_6-3567-stamped.pdf

194. Jacobson DM, Teutsch S. Environmental Scan of Integrated Approaches for Defining and Measuring Total Population Health by the Clinical Care System, the Government Public Health System and Stakeholder Organizations. A commissioned paper for the National Quality Forum, 2012. http://www.qualityforum.org/Publications/2012/06/An_Environmental_Scan_of_Integrated_Approaches_for_Defining_and_Measuring_Total_Population_Health.aspx

195. Beitsch L, Polyak G, Gold MR, Teutsch SM, Baciu A. Catapulting the Chasm: Or How to Avoid Wasting a Perfectly Good Fiscal Disaster. Am J Public Health. 2013 Jun;103(6):e11-13. ePub ahead of print April 18, 2013: e1-e3. doi: 10.2105/AJPH.2013.301274.

196. Teutsch S, Fielding JE. Rediscovering the core of public health. Frontiers in Public Health Services and Systems Research 2013;2(3) http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1047&context=frontiersinphssr

197. Teutsch SM, Chokshi DA, Stine NW, Fielding JE. HALE—unification theory for clinical medicine and population health. Discussion Paper, Institute of Medicine, Washington, DC. 2013 http://iom.edu/~/media/Files/Perspectives-Files/2013/Discussion-Papers/BPH-HALE.pdf

198. Tomines A, Readhead H, Readhead A, Teutsch S. Applications of Electronic Health Information in Public Health: Uses, Opportunities & Barriers. eGEMS, 2013. http://repository.academyhealth.org/egems/vol1/iss2/5/

199. Saha S, Dean B, Teutsch S, Borse R, Meltzer M, Bagwell D, Plough A, Fielding J. Assessing the efficiency of 2009 pandemic H1N1 vaccination through point of dispensing units in Los Angeles County . Emerging Inf Dis 2014;20(4):590-595.

200. Aldrich MC, Hidalgo B, Widome R, Briss P, Brownson RC, Teutsch SM. The Role of Epidemiology in Evidence-based Policy Making: A Case Study of Tobacco Use in Youth. Annals of Epidemiology (in press http://www.annalsofepidemiology.org/article/S1047-2797(14)00149-5/abstract )

23

201. Fischer KN Teutsch SM. Safe Summer Parks Programs: A Community Driven, Cross-Sector Collaboration to Reduce Violence and Improve Health in Los Angeles County. Institute of Medicine, Washington, DC. 2014 http://iom.edu/~/media/Files/Perspectives-Files/2014/Discussion-Papers/BPH-SafeSummerParks.pdf

202. Ahmed F, Teutsch S. Pay for performance and quality and outcomes frameworks for prevention. In Gorin SNS Prevention Practice in Primary Care. Oxford University Press, New York, 2014.

203. Teutsch SM, Fielding JE, Khoury MJ, Evan JP. Utility before business. Genet Med (http://www.nature.com/doifinder/10.1038/gim.2014.71).

204. Wernham A, Teutsch SM. Health impact assessment for big cities. J Publ Health Mgmt and Practice (in press)

205. Teutsch SM, Butler KM, Simon PA, Fielding JE. How Health Impact Assessments Shape Interventions. (AHRQ, in press)

206. Gase L, Kuo T, Teutsch S, Fielding J. Estimating the Costs and Benefits of Providing Free Public Transit Passes to Students in Los Angeles County: Lessons Learned in Applying a Health Lens to Decision-Making. Internatl. J Environ Research and Publ Health 2014, 11, 11384-11397; http://www.mdpi.com/1660-4601/11/11/11384

207. Kristensen AH, Flottemesch TJ, Maciosek MV, Jenson J, Barclay G, Ashe M, Sanchez EJ, Story M, Teutsch, SM, Brownson RC. Reducing childhood obesity through US federal policy: A microsimulation analysis. Am J Prev Med 2014;47(5):604-612. http://www.ajpmonline.org/article/S0749-3797(14)00377-8/fulltext

CDC Guidelines Methodology Working Group (Co-chair) CDC Guidelines: Improving the Quality. Atlanta, 1996. CDC Chronic Disease Planning Group

Centers for Disease Control. Positioning for Prevention: An analytical framework and background document for chronic disease activities. Atlanta, GA, August, 1986

US Preventive Services Task Force Screening for Skin Cancer: Recommendations and Rationale. Am J Prev Med 2001;20(3S):44-46

Screening for Bacterial Vaginosis in Pregnancy: Recommendations and Rationale. Am J Prev Med 2001;20(3S):59-61 Screening Adults for Lipid Disorders: Recommendations and Rationale. Am J Prev Med 2001;20(3S):73-76 Screening for Chlamydial Infection: Recommendations and Rationale. Am J Prev Med 2001;20(3S):90-94 Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rational. Ann Intern Med 2002;136:157-160 Newborn hearing screening: recommendations and rationale. Am Fam Physician. 2001;64:1995-1999. Screening for depression: recommendations and rationale. Ann Intern Med. 2002;136:760-764

24

Screening for colorectal cancer: recommendations and rationale. Ann Intern Med 2002;137:129-31. Behavioral counseling in primary care to promote physical activity: recommendations and rationale. Ann Intern Med. 2002;137:205-207 Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137:344-346. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-528. Screening for Prostate Cancer: Recommendation and Rationale. Ann Intern Med. 2002;137:915-916. Behavioral Counseling in Primary Care to Promote a Healthy Diet: Recommendations and Rationale. December 2002. Originally in Am J Prev Med 2003;24(1):93-100. Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale. Ann Intern Med. 2003;138:212-214. Screening for Gestational Diabetes Mellitus: Recommendations and Rationale. Ob Gyn. 2003;101:393-396. Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale. Ann Intern Med. 2003;139:51-55. Screening for High Blood Pressure: Recommendations and Rationale. Am J Prev Med 2003;25:159-64 Behavioral Interventions to Promote Breastfeeding: Recommendations and Rationale. Ann Fam Med 2003;1: 79-80 Counseling to Prevent Skin Cancer: Recommendations and Rationale of the US Preventive Services Task Force. MMWR 2003;51(RR-15):13-17.

Screening for Obesity in Adults: Recommendations and Rationale. Ann Intern Med 2003;139:930-932

Screening for Thyroid Disease: Recommendation Statement . Ann Intern Med 2004;140:125-127 Screening for Family Violence: Recommendation Statement of the US Preventive Services Task Force. Ann Intern Med 2003;140 Screening for Hepatitis C Virus Infection in Adults: Recommendation Statement. Ann Int Med 2004;140:462-464

Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: Recommendation Statement. Ann Int Med 2004;140: 554-556

Screening for Coronary Heart Disease: Recommendation Statement. Ann Int Med 2004;140:569-572

Prevention of Dental Caries in Preschool Children: Recommendations and Rationale. .Am J Prev Med 2004;26:326-9.

Lung Cancer Screening Recommendation Statement. Ann Int Med 2004;140:738-739

25

Screening for Suicide Risk: Recommendation and Rationale. Ann Int Med 2004;140:820-821 Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the USPSTF. Ann Intern Med 2005;142:855-860 Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement: Ann Intern Med 2005;143:355-61. Clinical Guidelines. Screening for Hemochromatosis: Recommendation Statement. U.S. Preventive Services Task Force. Ann Intern Med 2006;145: 204-208 Barton MB, Miller T, Wolff T,Petitti D, LeFevre M, Sawaya G, Yawn B, Guirguis-Blake J, Calonge N, Harris R, for the U.S. Preventive Services Task Force. How to Read the New Recommendation Statement: Methods Update from the U.S. Preventive Services Task Force. Ann Intern Med 2007;147:123-127

U.S. Preventive Services Task Force. Screening for Chlamydial Infection: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2007;147:128-134

U.S. Preventive Services Task Force. Counseling about Proper Use of Motor Vehicle Occupant Restraints and Avoidance of Alcohol Use while Driving: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2007;147:187-183. U.S. Preventive Services Task Force. Screening for Carotid Artery Stenosis: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2007;147:854-859.

U.S. Preventive Services Task Force. Screening for High Blood Pressure: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Ann Intern Med 2007;147:783-786.

U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148:759-65.

U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;48:214-219

Sawaya, G.F., Guirguis-Blake, J., LeFevre, M., et al. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit. Ann Intern Med 2007;147: 871-875.

U.S. Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force Recommendation. Ann Intern Med 2008;149:627-637.

U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:188-93. US Preventive Services Task Force. Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Pediatrics. 2008;122:143-8.

U.S. Preventive Services Task Force. Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2009;150:396-404.

U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 Oct 6;151(7):474-82.

26

Task Force on Community Preventive Services

Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. A report on recommendations of the Task Force on Community Preventive Services. MMWR 2001;50(RR-16):1-15 Increasing physical activity: a report on recommendations of the Task Force on Community Preventive Services. MMWR 2001;50(No. RR-18):1-14. Zaza S and Thompson RS. Reducing Injuries to Motor Vehicle Occupants. Systematic reviews of evidence, recommendations from the Task Force on Community Preventive Services, and expert commentary. Am J Prev Med. (Supplement), Nov. 2001 Promoting oral health: Interventions for preventing dental caries, oral and pharyngeal cancers, and sports-related craniofacial injuries. A report on recommendations of the Task Force on Community Preventive Services. MMWR 2001(RR-21);50:1-13. Community interventions to promote healthy social environments: Early childhood development and family housing. MMWR 2002(RR-1);51:1-8. Recommendations for healthcare system and self-management education interventions to reduce morbidity and mortality from diabetes. Am J Prev Med 2002;22(4S):10-14 Norris SL, Nichols PH, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, Isham G, Snyder SR, Carande-Kulis VG, Garfield S, BrissP, McCulloch D, and the TF on Community Preventive Services. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J. Prev Med 2002;22(4S):15-38 Norris SL, Nichols PH, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, Isham G, Snyder SR, Carande-Kulis VG, Garfield S, BrissP, McCulloch D, and the TF on Community Preventive Services. Increasing diabetes self-management education in community settings. A systematic review. Am J. Prev Med 2002;22(4S):39-66. Recommendations to increase physical activity in communities. Am J Prev Med 2002;22(4S);67-72. Kahn EB, Ramsey LT, Brownson RC, Heath GW, Howze EH, Powell KE, Stone EJ, Rajab MW, Corso P, and the Task Force on Community Preventive Services. The effectiveness of interventions to increase physical activity. A systematic review. Am J. Prev Med 2002;22(4S):73-107. Task Force on Community Preventive Services. Recommendations on selected interventions to prevent dental caries, oral and pharyngeal cancers and sports-related craniofacial injuries. Am J Prev Med 2002;23(1S):16-20. Truman BI, Gooch BF, Sulemana I, Gift JC, Horowitz AM, Evans CA, Griffin SO, Carande-Kulis VG, The Task Force on Community Preventive Services. Reviews of evidence on interventions to prevent dental caries, oral and pharyngeal cancers and sports-related craniofacial injuries. Am J Prev Med 2002;23(1S):21-54. Recommendations to Promote Healthy Social Environments. Am J Prev Med 2003;24(3S):21-24.

27

Anderson LE, Fielding JE, Fullilove MT, Scrimshaw SC, Carande-Kulis VG and the Task Force on Community Preventive Services. Methods for conducting systematic reviews of the evidence of effectiveness and economic efficiency of interventions to promote healthy social environments. Am J Prev Med 2003;24(3S):25-31. Anderson LE, Shinn CM, Fullilove MT, Scrimshaw SC, Fielding MT, Normand J, Carande-Kulis VG and the Task Force on Community Preventive Services. The effectiveness of early childhood development programs: A systematic review. Am J Prev Med 2003;24(3S):32-46. Anderson LE, St Charles J, Fullilove MT, Scrimshaw SC, Fielding MT, Normand J, and the Task Force on Community Preventive Services. Providing affordable family housing and reducing residential segregation by income: A systematic review. Am J Prev Med 2003;24(3S):47-67. Anderson LE, Scrimshaw SC, Fullilove MT, Fielding MT, Normand J, and the Task Force on Community Preventive Services. Culturally competent healthcare systems: A systematic review. Am J Prev Med 2003;24(3S):68-79. First reports evaluating the effectiveness of strategies for preventing violence: Early childhood home visitation and Firearms Laws. Findings from the Task Force on Community Preventive Services. MMWR 2003;52 (RR-14):1-23 Saraiya M, Glanz K, Briss P, Nichols P, White C, Das D. Preventing Skin Cancer: Findings of the Task Force on Community Preventive Services on Reducing Exposure to Ultraviolet Light. MMWR 2003;52 (RR-15): 1-12.

Therapeutic Foster Care for the Prevention of Violence.A Report on Recommendations of the Task Force on Community Preventive Services. MMWR 2004;53(RR10);1-8. Recommendation for use of mass media campaigns to reduce alcohol-impaired driving. Am J Prev Med 2004;27:66. Recommendations to prevent skin cancer by reducing exposure to ultraviolet radiation. Am J Prev Med 2004;27:467-70. Task Force on Community Preventive Services. Zaza S, Briss PA, Harris KW. The Guide to Community Preventive Services: What Works to Promote Health. Oxford University Press, NY, 2005. Interventions to reduce injury and death from violence: systematic reviews of evidence, recommendations from the Task Force on Community Preventive Services, and Expert Commentary. Am J Prev Med 2005;28(suppl 2):1-92. Task Force on Community Preventive Services. Recommendations to reduce violence through early childhood home visitation, therapeutic foster care, and firearms laws. pp. 6-10 Bilukha O, Hahn RA, Crosby A, Fullilove FT, Liberman A, Moscicki E, Snyder S, Tuma F, Corso P, Schofield A, Briss PA, Task Force on Community Preventive Services. The effectiveness of early childhood home visitation in preventing violence: A systematic review. pp. 11-39 Hahn RA, Bilukha A, Corsby A, Fullilove MT, Liberman A, Moscicki E, Snyder S, Tuma F, Briss PA, Task Force on Community Preventive Services. Firearms laws and the reduction of violence: A systematic review. pp. 40-71

28

Hahn RA, Bilukha O, Lowy J, Crosby A, Fullilove MT, Liberman A, Moscicki E, Snyder S, Tuma F, Corso P, Schfield A, Task Force on Community Preventive Services. The effectiveness of therapeutic foster care for the prevention of violence: A systematic review. pp. 72-90 Willis BC, Ndiaye SM, Hopkins DP, Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk. A report of the Task Force on Community Preventive Services. MMWR 2005;54 (RR-5):1-11 Task Force on Community Preventive Services. Recommendations to improve targeted vaccination coverage among high-risk adults. Am J Prev Med 2005;28(suppl 5S):231-237. Ndiaye SM, Hopkins DP, Smith SJ, Hinman AR, Briss PA Task fe on Community Preventive Services. Methods for conducting systematic reviews of targeted vaccinations for the Guide to Community Preventive Services. Am J Prev Med 2005;28(5S):238-247. Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, Willis B, Task Force on Community Preventive Services. Interventions to improve influenza, pneumococcal polysaccharide, and Hepatitis B vaccination coverage among high-risk adults. A sysgtematic review. Am J Prev Med 2005;28(5S):248-279. Ditter SM, Elder RW, Shults RA, Sleet DA, Compton R, Nichols JL, Task Force on Community Preventive Services. Effectiveness of designated driver programs for reducing alcohol-impaired driving: A systematic review. Am J Prev Med 2005;28(5S):280-287. Elder RW, Nichols JL, Shults RA, Sleet DA, Barrios LC, Compton R, Task Force on Community Preventive Services. Effectiveness of school-based programs for reducing drinking and driving and riding with drinking drivers: A systematic review. Am J Prev Med 2005;28(5S):288-304. Katz DL, O’Connell M, Ming-Chin Y, Hawaz H, Njike V, Anderson LM, Cory S, Dietz W. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings. A report of the Task Force on Community Preventive Services. MMWR 2005;54 (No. RR-10):1-12. Hahn R, Fuqua-Whitley D et al. The effectiveness of universal school-based programs for the prevention of violent and aggressive behavior. A report of the Task Force on Community Preventive Services. MMWR 2007;56 (RR-7):1-12. Hahn R, McGowan A, et al. Effects on violence of laws and policies facilitating the transfer of youth from the juvenile justice to the adult justice system. A report of the Task Force on Community Preventive Services. MMWR 2007;56 (RR-9):1-11. Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, Coughlin SS, Kalra GP, Chattopadhyay S; Task Force on Community Preventive Services. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med. 2008;35(1 Suppl):S67-74. Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, Habarta N, Wilson KM, Chattopadhyay S, Leeks K; Task Force on Community Preventive Services. Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med. 2008;35(1 Suppl):S56-66. Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC, Mullen PD, Coughlin SS, Briss PA; Task Force on Community Preventive Services.

29

Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med. 2008;35(1 Suppl):S34-55. Baron RC, Rimer BK, Coates RJ, Kerner J, Mullen PD, Chattopadhyay S, Briss PA; Task Force on Community Preventive Services. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers. Am J Prev Med. 2008;35(1 Suppl):S26-33 Task Force on Community Preventive Services. Recommendations for client- and provider-directed interventions to increase breast, cervical, and colorectal cancer screening. Am J Prev Med. 2008;35(1 Suppl):S21-5.

Evaluation of Genomic Applications in Practice and Prevention Working Group

Recommendations from the EGAPP Working Group: Testing for P450 cytochrome polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors. Genetics in Medicine 2007;9:819-825.

Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine 2009;11(1):35-41.

Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Genetics in Medicine 2009;11(1):15-20. Recommendations from the EGAPP Working Group: Can tumor gene expression profiling improve outcomes in patients with breast cancer? Genetics in Medicine 2009;11(1):66-73. Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members Genetics in Medicine 2011. 13(1):67-76. http://journals.lww.com/geneticsinmedicine/Fulltext/2011/01000/Recommendations_from_the_EGAPP_Working_Group_.11.aspx

Secretary's Advisory Committee on Genetics, Health, and Society

Policy Issues Associated with Undertaking a New Large US Population Cohort Study of Genes, Environment, and Disease. HHS, 2007. http://www4.od.nih.gov/oba/sacghs/reports/sacghs_lps_report.pdf U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services. HHS, 2008. http://www4.od.nih.gov/oba/sacghs/reports/sacghs_oversight_report.pdf

Realizing the Potential of Pharmacogenomics: Opportunities and Challenges. HHS, 2008 http://www4.od.nih.gov/oba/sacghs/reports/SACGHS_PGx_Report.pdf

30

Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests: Report of the Secretary's Advisory Committee on Genetics, Health, and Society (April 2010). http://oba.od.nih.gov/oba/sacghs/reports/SACGHS_patents_report_2010.pdf

Evans JP, Dale DC, Fomous C for SACGHS. Preparing for the Consumer-Driven Genomic Age. N Engl J Med 2010;363:1099-1103.

Genetics Education and training. HHS, 2011. http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_education_report_2011.pdf

Institute of Medicine

Institute of Medicine. State of the USA Health Indicators: Letter Report. 2009. Washington, DC: The National Academies Press.

Institute of Medicine. Leading Health Indicators for Healthy People 2020: Letter Report. 2011. Washington, DC: The National Academies Press.

Institute of Medicine. For the Public’s Health: The Role of Measurement in Action and Accountability, 2011. Washington, DC: The National Academies Press

Institute of Medicine. For the Public’s Health: Revitalizing Law and Policy to Meet New Challenges, 2011. Washington, DC: The National Academies Press

Institute of Medicine. For the Public’s Health: Investing in a Healthier Future, 2012. Washington, DC: The Academies Press. Institute of Medicine. An Integrated Framework for Assessing the Value of Community-Based Prevention, 2012. Washington, DC: The National Academies Press. http://www.iom.edu/Reports/2012/An-Integrated-Framework-for-Assessing-the-Value-of-Community-Based-Prevention.aspx Institute of Medicine. 2013. Core measurement needs for better care,better health, and lower costs: Counting what counts: Workshop summary. Washington, DC: The National Academies Press. http://www.nap.edu/catalog.php?record_id=18333 Institute of Medicine. 2013. Toward Quality Measures for Population Health and the Leading Health Indicators. Washington, DC: The National Academies Press.

Other Work Group Publications:

Howard D, Cordell R, McGowan JE Jr., Packard RM, Scott RD II, Solomon SL for the Workshop Group. Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention-Emory Workshop

Partnership for Prevention Medicare Advisory Committee. A Better Medicare for Healthier Seniors: Recommendations to Modernize Medicare’s Prevention Policies , 2003 Hill, JO, Sturm R, Orleans CT, eds. An economic analysis of eating and physical activity behaviors: Exploring effective strategies to combat obesity. Am J Prev Med 2004;27(3S):i-viii, 111-178. United Health Foundation. America’s Health: State Health Ranking, 2004 Edition. (Methods Committee)

31

United Health Foundation. America's Health. A Call to Action for People and Their Communities. 2006 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for People and Their Communities, 2007 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for People and Their Communities, 2008 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for People and Their Communities, 2009 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for Individuals and Their Communities, 2010 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for Individuals and Their Communities, 2011 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for Individuals and Their Communities, 2012 Edition. (Scientific Advisory Committee) America's Health Rankings. A Call to Action for Individuals and Their Communities, 2013 Edition. (Scientific Advisory Committee) Glaser J, Henley D, Downing G, Brinner KM, Personalized Health Care Workgroup of the American Health Information Community. Advancing Personalized Health Care through Health Information Technology: An Update from the American Health Information Community's Personalized Health Care Workgroup. J Am Med Inform Assoc. 2008;15:391-396.

32